|
Discontinued Operations (Discontinued Operations in the Company's Consolidated Statement of Financial Position) (Details) (USD $)
In Thousands, unless otherwise specified |
Sep. 30, 2014
|
Dec. 31, 2013
|
|---|---|---|
| Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||
| Assets of discontinued operations | $ 0 | $ 3,029 |
|
Tranzyme Pharma Inc. [Member]
|
||
| Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||
| Prepaid expenses and other current assets | 0 | 178 |
| Property and equipment | 0 | 356 |
| Intangible assets, net | 0 | 2,053 |
| Goodwill | 0 | 442 |
| Assets of discontinued operations | 0 | 3,029 |
| Accounts payable | 0 | 106 |
| Deposit on sale of assets | 0 | 3,000 |
| Accrued liabilities | 0 | 397 |
| Liabilities of discontinued operations | $ 0 | $ 3,503 |